Within the VitD pathway, the VitD binding protein (VDBP also known as GC) was significantly reduced in OSCC samples (Figure 6E), suggesting an impairment in the transport of VitD from the skin to circulation as previously reported (29), which suggest that this metabolite is more concentrated in cancer samples. The gene discussed is GC; the disease is cancer.